Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Vitamin D (17.9 ng/mL vs. 29.2 ng/mL) and trace elements (zinc, selenium) were significantly depleted (all p < 0.001).

Source: Nutritional status and organ function on postoperative day 14. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were categorized into PICS and non-PICS groups based on criteria assessed at postoperative day 14.

Source: Abstract.

This was a single-center retrospective cohort study analyzing clinical data of SAP patients admitted from July 2022 to March 2025.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Epidemiological characteristics, SAP-associated sepsis, and prognostic analysis of persistent inflammation: immunosuppression-catabolism syndrome in severe acute pancreatitis patients after percutaneous drainage: a retrospective study

Cohort study · Frontiers in Cell and Developmental Biology · 2026

Original publication title

Epidemiological characteristics, SAP-associated sepsis, and prognostic analysis of persistent inflammation: immunosuppression: catabolism syndrome in severe acute pancreatitis patients after percutaneous drainage: a retrospective study

Tao Su; Dianlong Liu; Xin Chen

Copyright © 2026 Su, Liu and Chen.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

SAP patients after percutaneous drainage have a high PICS incidence (37.5%). SAP-associated sepsis was strongly and independently associated with PICS development, with the median sepsis-to-PICS interval of approximately 9.5 days, suggesting a potential period of heightened vulnerability warranting further prospective investigation. PICS substantially worsens prognosis, underscoring the need for early identification and targeted immunomodulatory and nutritional interventions in SAP patients with concurrent sepsis.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study aims to analyze the incidence and epidemiological characteristics of persistent inflammation: immunosuppression: catabolism syndrome (PICS) in severe acute pancreatitis (SAP) patients after percutaneous drainage, investigate the role of SAP-associated sepsis in PICS development, identify independent risk factors for PICS, and evaluate its impact on short: and long-term prognosis.

Source: Objective

Abstract: What methods does the paper describe?

A retrospective analysis of 176 SAP patients who underwent percutaneous drainage from July 2022 to March 2025. SAP-associated sepsis was defined using the Sepsis-3 criteria (2016). Patients were categorized into PICS and non-PICS groups based on criteria assessed at postoperative day 14. Multivariate logistic regression with sepsis as a covariate identified independent PICS risk factors; Kaplan: Meier and Cox regression evaluated prognostic impact.

Source: Methods

Abstract: Results

PICS incidence was 37.5%. SAP-associated sepsis occurred in 78.8% of PICS patients vs. 31.8% of non-PICS patients (p < 0.001); the median time from sepsis onset to PICS was 9.5 days (IQR 6.0 to 14.0). Multivariate analysis confirmed SAP-associated sepsis (OR = 2.971, 95% CI 1.390 to 6.348, p = 0.005) as an independent PICS risk factor alongside age, APACHE II score, sequential organ failure assessment (SOFA) score, pancreatic necrosis >50%, CRP, and procalcitonin; preoperative albumin was protective. The integrated prediction model (AUC = 0.891) improved upon the model excluding sepsis (AUC = 0.876).

PICS patients had a 6-month survival rate of 72.7% vs. 95.5% (p < 0.001), and PICS was an independent risk factor for post-discharge mortality (HR = 4.823, p < 0.001).

Source: Results

Abstract: Conclusion

SAP patients after percutaneous drainage have a high PICS incidence (37.5%). SAP-associated sepsis was strongly and independently associated with PICS development, with the median sepsis-to-PICS interval of approximately 9.5 days, suggesting a potential period of heightened vulnerability warranting further prospective investigation. PICS substantially worsens prognosis, underscoring the need for early identification and targeted immunomodulatory and nutritional interventions in SAP patients with concurrent sepsis.

Source: Conclusion
Authors’ abstract

Objective

This study aims to analyze the incidence and epidemiological characteristics of persistent inflammation: immunosuppression: catabolism syndrome (PICS) in severe acute pancreatitis (SAP) patients after percutaneous drainage, investigate the role of SAP-associated sepsis in PICS development, identify independent risk factors for PICS, and evaluate its impact on short: and long-term prognosis.

Methods

A retrospective analysis of 176 SAP patients who underwent percutaneous drainage from July 2022 to March 2025. SAP-associated sepsis was defined using the Sepsis-3 criteria (2016). Patients were categorized into PICS and non-PICS groups based on criteria assessed at postoperative day 14. Multivariate logistic regression with sepsis as a covariate identified independent PICS risk factors; Kaplan: Meier and Cox regression evaluated prognostic impact.

Results

PICS incidence was 37.5%. SAP-associated sepsis occurred in 78.8% of PICS patients vs. 31.8% of non-PICS patients (p < 0.001); the median time from sepsis onset to PICS was 9.5 days (IQR 6.0 to 14.0). Multivariate analysis confirmed SAP-associated sepsis (OR = 2.971, 95% CI 1.390 to 6.348, p = 0.005) as an independent PICS risk factor alongside age, APACHE II score, sequential organ failure assessment (SOFA) score, pancreatic necrosis >50%, CRP, and procalcitonin; preoperative albumin was protective. The integrated prediction model (AUC = 0.891) improved upon the model excluding sepsis (AUC = 0.876).

PICS patients had a 6-month survival rate of 72.7% vs. 95.5% (p < 0.001), and PICS was an independent risk factor for post-discharge mortality (HR = 4.823, p < 0.001).

Conclusion

SAP patients after percutaneous drainage have a high PICS incidence (37.5%). SAP-associated sepsis was strongly and independently associated with PICS development, with the median sepsis-to-PICS interval of approximately 9.5 days, suggesting a potential period of heightened vulnerability warranting further prospective investigation. PICS substantially worsens prognosis, underscoring the need for early identification and targeted immunomodulatory and nutritional interventions in SAP patients with concurrent sepsis.

Publication and source details

Original title: Epidemiological characteristics, SAP-associated sepsis, and prognostic analysis of persistent inflammation: immunosuppression: catabolism syndrome in severe acute pancreatitis patients after percutaneous drainage: a retrospective study

Tao Su; Dianlong Liu; Xin Chen

Frontiers in Cell and Developmental Biology · 2026

* Correspondence: Xin Chen, chenxin10040905@163.com
†

These authors have contributed equally to this work

Copyright © 2026 Su, Liu and Chen.2026Su, Liu and Chenhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This study was funded by the National High Level Hospital Clinical Research Funding (2023-NHLHCRF-BQ-22).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:20:05.762732+00:00

DOI: 10.3389/fcell.2026.1828002 · PMC13290732